Overview

Intranasal Dexmedetomidine Versus Intranasal Midazolam for Emergence Delirium Prevention

Status:
Completed
Trial end date:
2019-10-10
Target enrollment:
Participant gender:
Summary
This study is a double-blind clinical trial, in pediatric patients aged 1-12 years with physical status ASA (American Society of Anesthesiology) 1 and 2 who underwent eye surgery under general anesthesia using Sevoflurane inhalation agents, in investigator institution during February-May 2019.. There were 64 children obtained by consecutive sampling, who underwent eye surgery in investigator institution during February-May 2019. The subjects then grouped into dexmedetomidine group and midazolam group. Effectiveness was assessed from Emergence Delirium (ED) events, recovery time, and post-premedication desaturation events. Data analysis using Chi Square test and Mann-Whitney test.
Phase:
Phase 4
Details
Lead Sponsor:
Indonesia University
Treatments:
Dexmedetomidine
Midazolam